Latest filing published 05 Jun 2026 for Denali Therapeutics Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Peter S. Klein, listed as board member, has filed trades across 4 companies (mainly through SEC (Form 4)), most often in Accolade, Inc., Denali Therapeutics Inc. and F5, Inc. Between 11 May 2021 and 3 June 2026, the trades on record add up to 25 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 5 June 2026 came the latest disclosure, a share grant in Denali Therapeutics Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 25 declarations